Pure Green Pharmaceuticals
West Bloomfield, US · Founded 2019 · Delaware corporation
Founders & leadership
SG
STEPHEN GOLDNERNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.4M disclosed across 1 round · 2022
▶$5.4MraisedNov 2022 · 7 investors · PharmaceuticalsRule 506(b)
▶$5.4MraisedNov 2022 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN GOLDNERExecutive Officer, Director
- Offering amount
- $7.8M
- Amount sold
- $5.4M
- Minimum investment
- $80K
- Proceeds to insiders
- $360K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pure Green Pharmaceuticals raised?
- Pure Green Pharmaceuticals has disclosed $5.4M raised across 1 round.
- Where is Pure Green Pharmaceuticals headquartered?
- Pure Green Pharmaceuticals is headquartered in West Bloomfield, US.